Takeaways from 2020 Capital Markets Day
26/11/20 -"Novartis unveiled promising performance targets at its 2020 CMD. Besides striving for healthy top-line growth – driven by diverse innovations, the group also plans to improve operating margins – even ..."
Pages
65
Language
English
Published on
26/11/20
You may also be interested by these reports :
17/11/25
Our 2025 estimates have been revised significantly, following a substantial guidance upgrade during Q3 results, driven by stronger-than-expected ...
14/11/25
The Q3 results surpassed expectations, driven by strong demand for depression and migraine medicines. Consequently, the management upgraded its ...
13/11/25
The Q3 results exceeded the street’s expectations, driven by healthy top-line growth across all segments and a profitability beat (also aided by a ...
12/11/25
The Q3 profitability beat was driven by Crop Science, though Pharmaceuticals witnessed lower operating profits. Also, the management maintained its ...